Quest Diagnostics (DGX) Earnings Date, Estimates & Call Transcripts → Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (From Paradigm Press) (Ad) Free DGX Stock Alerts $134.26 -1.16 (-0.86%) (As of 04/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateJul. 24EstimatedActual EPS (Apr. 23) $2.04 Beat By $0.18 Consensus EPS (Apr. 23) $1.86 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Quest Diagnostics Earnings AlertsEnter your email address below to receive the latest news and earnings results for DGX and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueDGX Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.DGX Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Paradigm PressForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISYou might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.Click here to find out that this 8,788% cryptocurrency is. Quest Diagnostics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20243$1.84$2.17$1.96 Q2 20243$2.23$2.32$2.28 Q3 20243$2.18$2.31$2.26 Q4 20243$1.92$2.29$2.13 FY 202412$8.17$9.09$8.63 Q1 20252$2.26$2.30$2.28 Q2 20252$2.34$2.47$2.41 Q3 20252$2.31$2.44$2.38 Q4 20252$2.33$2.35$2.34 FY 20258$9.24$9.56 $9.40DGX Earnings Date and InformationQuest Diagnostics last announced its quarterly earnings results on April 23rd, 2024. The medical research company reported $2.04 EPS for the quarter, beating the consensus estimate of $1.86 by $0.18. The company had revenue of $2.37 billion for the quarter, compared to analysts' expectations of $2.29 billion. Its revenue for the quarter was up 1.7% compared to the same quarter last year. Quest Diagnostics has generated $7.43 earnings per share over the last year ($7.43 diluted earnings per share) and currently has a price-to-earnings ratio of 18.1. Earnings for Quest Diagnostics are expected to grow by 7.40% in the coming year, from $8.78 to $9.43 per share. Quest Diagnostics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based off prior year's report dates.Read More Quest Diagnostics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/24/2024Estimated)------- 4/23/2024Q1 2024$1.86$2.04+$0.18$2.36$2.29 billion$2.37 billion 2/1/2024Q4 2023$2.11$2.15+$0.04$2.60$2.25 billion$2.29 billion 10/24/2023Q3 2023$2.19$2.22+$0.03$2.48$2.27 billion$2.30 billion 7/26/2023Q2 2023$2.23$2.30+$0.07$2.55$2.25 billion$2.34 billion 4/27/2023Q1 2023$1.97$2.04+$0.07$2.30$2.20 billion$2.33 billion 2/2/2023Q4 2022$1.90$1.98+$0.08$3.09$2.26 billion$2.33 billion Get the Latest News and Ratings for DGX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quest Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 10/20/2022Q3 2022$2.17$2.36+$0.19$2.55$2.34 billion$2.49 billion 7/21/2022Q2 2022$2.26$2.36+$0.10$2.76$2.34 billion$2.45 billion 4/21/2022Q1 2022$2.91$3.22+$0.31$3.52$2.64 billion$2.61 billion 2/3/2022Q4 2021$3.35$3.33($0.02)$3.54$2.66 billion$2.74 billion 10/20/2021Q3 2021$2.88$3.96+$1.08$3.90$2.52 billion$2.77 billion 7/22/2021Q2 2021$2.87$3.18+$0.31$1.40$2.38 billion$2.55 billion Quest Diagnostics Earnings - Frequently Asked Questions When is Quest Diagnostics's earnings date? Quest Diagnostics has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, July 24th, 2024 based off last year's report dates. Learn more on DGX's earnings history. Did Quest Diagnostics beat their earnings estimates last quarter? In the previous quarter, Quest Diagnostics (NYSE:DGX) reported $2.04 earnings per share (EPS) to beat the analysts' consensus estimate of $1.86 by $0.18. Learn more on analysts' earnings estimate vs. DGX's actual earnings. How can I listen to Quest Diagnostics's earnings conference call? The conference call for Quest Diagnostics's latest earnings report can be listened to online. Listen to Conference Call How can I read Quest Diagnostics's conference call transcript? The conference call transcript for Quest Diagnostics's latest earnings report can be read online. Read Transcript How can I view Quest Diagnostics's earnings report? Quest Diagnostics's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does Quest Diagnostics generate each year? Quest Diagnostics (NYSE:DGX) has a recorded annual revenue of $9.25 billion. How much profit does Quest Diagnostics generate each year? Quest Diagnostics (NYSE:DGX) has a recorded net income of $854 million. DGX has generated $7.43 earnings per share over the last four quarters. What is Quest Diagnostics's price-to-earnings ratio? Quest Diagnostics (NYSE:DGX) has a trailing price-to-earnings ratio of 18.07 and a forward price-to-earnings ratio of 15.29. The price/earnings-to-growth ratio is 2.92. What is Quest Diagnostics's EPS forecast for next year? Quest Diagnostics's earnings are expected to grow from $8.78 per share to $9.43 per share in the next year, which is a 7.40% increase. More Earnings Resources from MarketBeat Related Companies: Laboratory Co. of America Earnings Date Exact Sciences Earnings Date Natera Earnings Date Teva Pharmaceutical Industries Earnings Date Viatris Earnings Date Neurocrine Biosciences Earnings Date BeiGene Earnings Date Karuna Therapeutics Earnings Date Revvity Earnings Date Shockwave Medical Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future OutlookCSX Co.: The Railroad Powering Ahead with an Earnings Beat What's Driving Tesla Lower Ahead of its Earnings?Blackrock vs. State Street: Earnings in a Volatile MarketWhat to Expect From the Q1 Earnings Reporting SeasonLululemon Stock Implodes Post Earnings, Guidance Muted This page (NYSE:DGX) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsProtect Your Bank Account Before It’s Too LateWeiss RatingsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressWhy Big Pharma is Investing Billions in This BiotechBehind the MarketsJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest Diagnostics Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
